Durvalumab versus placebo with chemoradiotherapy for locally advanced cervical cancer (CALLA): a randomised, double-blind, phase 3 trial

Bradley J. Monk, Jyoti Mayadev, Xiaohua Wu et al.|The Lancet Oncology|2023

Cited by 214